Australian Journal of Primary Health Australian Journal of Primary Health Society
The issues influencing community health services and primary health care
RESEARCH ARTICLE

Theorising stigma and the experiences of injecting drug users in Australia

Christine Tindal A , Kay Cook A C and Nena Foster A B
+ Author Affiliations
- Author Affiliations

A School of Health and Social Development, Deakin University, 221 Burwood Highway, Burwood, Vic. 3125, Australia.

B Present address: School of Health and Bioscience, University of East London, Stratford Campus, Water Lane, London E15 4LZ, UK.

C Corresponding author. Email: kay.cook@deakin.edu.au

Australian Journal of Primary Health 16(2) 119-125 https://doi.org/10.1071/PY09026
Published: 19 May 2010

Abstract

This paper examines the stigma of injecting drug use as an underlying factor in the poor health status of Australian injecting drug users. Drawing on various models of stigma described in the literature, we examine injecting drug users’ experiences. As a case study, examples from Victorian (specifically Melbourne) policy and practice are included to exemplify community and societal attitudes towards injecting drug users and the implications of these for injecting drug user health. We conclude that redressing the negative effects of stigma requires political will, financial support, increased community commitment and a better understanding of the links between the social determinant of health and the poor health status of injecting drug users. Without reducing the stigma of injecting drug use the health of this marginalised population is likely to get worse, which will have broader negative population health effects.


References


Anti Discrimination Board of New South Wales (2001) C-Change: report of the enquiry into hepatitis C related discrimination. Anti-Discrimination Board of New South Wales, Sydney.

Australian Federation of AIDS Organisations (2004) Drug use, disability and discrimination. HIV Australia 3(4). Available at http://www.afao.org.au/view_articles.asp?pxa=ve&pxs=103&pxsc=127&pxsgc=139&id=479 [Verified March 2010]

Australian Institute of Health and Welfare (2008) 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series number 20. Cat. No. PHE 98. AIHW, Canberra.

Bennett G (2004) Blacklisted in the city: how stigma affects primary health care for people who inject drugs. Australian Journal of Primary Health 10(2), 121–128.
CrossRef |

Capitanio J, Herek G (1999) AIDS-related stigma and attitudes toward injecting drug users among black and white Americans. The American Behavioral Scientist 42(7), 1144–1157.

Collins DJ , Lapsley HM (2008) ‘The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05.’ (Commonwealth of Australia: Canberra)

Crofts N (1999) The meaning of hepatitis C for the community. Australian Family Physician 28, 60–63.

Crofts N , Dore G , Locarni S (2001) ‘Hepatitis C: an Australian perspective.’ (IP Communications: Melbourne)

Day C, Ross J, Dolan K (2003) Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug and Alcohol Review 22, 317–321.
CrossRef | PubMed |

Degenhardt L, Day C, Dietze P, Pointer S (2005) Effects of a sustained heroin shortage in three Australian states. Society for the Study of Addiction 100, 908–920.
CrossRef |

Devine P, Plant E, Harrison K (1999) The problem of ‘us’ versus ‘them’ and AIDS stigma. The American Behavioral Scientist 42(7), 1212–1228.
CrossRef |

Dietze P , Keleher H (2004) Chapter 17: illicit drugs. In ‘Understanding health: a determinants approach’. (Eds H Keleher and B Murphy) pp. 233–239. (Oxford University Press: South Melbourne)

Doab A, Treloar C, Dore G (2005) Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clinical Infectious Diseases 40(Suppl. 5), 313–320.
CrossRef |

Dolan K , MacDonald M , Silins E , Topp L (2005) ‘Needle and syringe programs: a review of the evidence.’ (Australian Government Department of Health and Aging: Canberra)

Drug Policy Expert Committee (2000) ‘Drugs: responding to the issues, engaging the community, stage one report.’ (Drug Policy Expert Committee: Melbourne)

Elliott A, Chapman S (2000) ‘Heroin hell of their own making’: construction of heroin users in the Australian press 1992–97. Drug and Alcohol Review 19, 191–201.
CrossRef |

Fraser S, Treloar C (2006) ‘Spoiled identity’ in hepatitis C infection: the binary logic of despair. Critical Public Health 16, 99–110.
CrossRef |

Gifford S, O’Brien M, Bammer G, Banwell C, Stoove M (2003) Australian women’s experiences of living with hepatitis C virus: results from a cross-sectional survey. Journal of Gastroenterology and Hepatology 18, 841–850.
CrossRef | PubMed |

Gifford S, O’Brien M, Smith A (2005) Australian men’s experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology and Hepatology 20, 79–86.
CrossRef | PubMed |

Goffman E (1963) ‘Stigma: notes on the management of spoiled identity.’ (Simon and Schuster: New York)

Green G (1997) Evangelical leaders and people with HIV. AIDS Care 9(6), 715–726.

Haber PS, Young MM, Dorrington L, Jones A, Kaldor J, De Kanzow S, Rawlinson WD (2007) Transmission of hepatitis C virus by needle-stick injury in community settings. Journal of Gastroenterology and Hepatology 22(11), 1882–1885.
CrossRef | PubMed |

Heijnders M, Van Der Meij S (2006) The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychology Health and Medicine 11(3), 353–363.
CrossRef |

Herek G, Glunt E (1988) An epidemic of stigma: public reactions to AIDS. The American Psychologist 43(11), 886–891.
CrossRef | PubMed |

Herek G, Capitanio J, Widaman K (2002) Stigma, social risk and health policy: public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychology 22(5), 533–540.
CrossRef |

Hopwood M, Treloar C (2004) Receiving a hepatitis C-positive diagnosis. Internal Medicine Journal 34, 526–531.
CrossRef | PubMed |

Hopwood M, Treloar C, Bryant J (2006) Hepatitis C and injecting-related discrimination within healthcare in New South Wales, Australia. Drugs Education Prevention & Policy 13, 61–75.
CrossRef |

Kimber J, Dolan K, Wodak A (2005) Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug and Alcohol Review 24, 21–24.
CrossRef | PubMed |

Lenton S, Phillips M (1997) Mobilising public support for providing needles to drug injectors. The International Journal on Drug Policy 8(2), 101–110.

Link B , Phelan J (2001) On stigma and its public health implications. Paper presented at the ‘Stigma and global Health: developing a research agenda conference, Bethesda, MD, USA, 5–7 September 2001’. Available at http://www.stigmaconference.nih.gov/FinalLinkPaper.html [Verified 29 July 2006]

Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M , et al. (2008) Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372(9651), 1733–1745.
CrossRef | PubMed |

Mendes P (2001) Nimbyism vs social inclusion: local communities and illicit drugs. Youth Studies Australia 20(2), 17–22.

National Centre in HIV Social Research (2001) Appendix E an epidemic of difference: a social analysis of hepatitis C-related discrimination. In ‘C-Change: Report of the Enquiry into Hepatitis C related Discrimination’. pp. 136–147. (Anti Discrimination Board of New South Wales: Sydney)

Puplick C (2001) Hepatitis C and discrimination. In ‘Hepatitis C: an Australian perspective’. (Eds N Crofts, G Dore, S Locarni) pp. 194–208. (IP Communications: Melbourne)

Razali K, Thein H, Bell J, Cooper-Stanbury M, Dolan K , et al. (2007) Modelling the hepatitis C virus epidemic in Australia. Drug and Alcohol Dependence 91(2–3), 228–235.
CrossRef | PubMed |

Reid G , Crofts N , Hocking J (2000) ‘Needs analysis for primary health care among the street drug-using community in Footscray.’ (The Centre for Harm Reduction, Macfarlane Burnet Centre for Medical Research: Melbourne)

Reidpath D, Chan K (2005) A method for the quantitative analysis of the layering of HIV-related stigma. AIDS Care 17(4), 425–432.
PubMed |

Reidpath D, Chan K, Gifford S, Allotey P (2005) ‘He hath the French pox’: stigma, social value and social exclusion. Sociology of Health & Illness 27(4), 468–489.
CrossRef | PubMed |

Rowe J (2005) Laying the foundations: addressing heroin use among the ‘street homeless’. Drugs Education Prevention & Policy 12(1), 47–59.
CrossRef |

Sartorius N (2006) Lessons from a 10-year global programme against stigma and discrimination because of an illness. Psychology Health and Medicine 11(3), 383–388.
CrossRef |

Scambler G (2006) Sociology, social structure and health-related stigma. Psychology Health and Medicine 11(3), 288–295.
CrossRef |

Scambler G, Heijnders M, Van Brakel W (2006) Understanding and tackling health-related stigma. Psychology Health and Medicine 11(3), 269–270.
CrossRef |

Temple-Smith M, Gifford S, Stoove M (2004) The lived experience of men and women with hepatitis C: implications for support needs and health information. Australian Health Review 27(2), 47–57.
CrossRef |


Treloar C, Hopwood M (2004) Infection control in the context of hepatitis C disclosure: implications for education of healthcare professionals. Education for Health 17, 183–191.
CrossRef | PubMed |

Victorian Government (2006) Victorian Drug Strategy 2006–09: improving health, reducing harm. Victorian Department of Human Services, Melbourne.

Weiss M, Ramakrishna J, Somma D (2006) Health-related stigma: rethinking concepts and interventions. Psychology Health and Medicine 11(3), 277–287.
CrossRef |

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW (2004) Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal 171(7), 731–734.
CrossRef | PubMed |








Export Citation Cited By (16)